WVXU: FDA says decongestant in over-the-counter cold medicines doesn't work

An advisory panel to the Food and Drug Administration agreed unanimously last month that an ingredient found in many over-the-counter cold medicines called phenylephrine doesn't work to clear nasal congestion when taken orally.

Ahmad Sedaghat, MD, PhD, director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery at the University of Cincinnati's College of Medicine and a UC Health physician, and Michael Hegener, PharmD, associate professor of pharmacy at UC's James L. Winkle College of Pharmacy, joined WVXU's Cincinnati Edition to discuss the recent announcement.

Hegener explained phenylephrine is a decongestant that works by shrinking blood vessels in the nose, which opens up the nasal cavities and helps people breathe easier. Many drug companies replaced the drug pseudoephedrine with phenylephrine in their over the counter products after federal legislation made it harder to access pseudoephedrine because it can be used to make methamphetamines.

Hegener noted the FDA recommendation was for oral tablet products that contain phenylephrine, not nasal sprays.

"The effectiveness of the nasal spray has been established more firmly and that’s not what’s up for debate today," Hegener said. "It’s the oral form that everyone is talking about."

Sedaghat said oftentimes cold medicines have a combination of active drugs in them, so consumers may not want to throw away products with phenylephrine because the other ingredients could still be helpful.

"One thing that I’ve also recommended to patients to do is to look at their favorite cold medication and see what the active ingredients are in that medication, and because that cold medication will potentially have had other ingredients that will not get pulled off of shelves, the patients can go ahead and get the other medications that are in their favorite combination cold medicine," he said.

While effective, Sedaghat said the nasal sprays can raise blood pressure and become addictive, so patients are advised to use the spray no more than two to three days in a row. Patients can also seek out saline rinses to help clear congestion, he said.

Listen to the Cincinnati Edition segment.

Featured photo at top of a man sneezing. Photo/dragana991/iStock.

Related Stories

9928 Results
1

President picks exceptional talent

April 28, 2021

The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

2

Grad students earn president's highest honor

April 28, 2021

The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

3

UC student leads effort to clean up campus adjacent Coy Field

April 7, 2021

Karthikeyan Sakthivel, a senior medical sciences undergraduate at the University of Cincinnati, has adopted Coy Field in an attempt to keep the green space clean and ready for use by UC students, area high schoolers and the community. Sakthivel is planning another cleanup event for Coy Field, which is adjacent to the university campus.

5

Finding community and building a future

July 9, 2021

As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”

8

UC Receives $1.9 Million to Study Pain

February 15, 2016

Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.

9

MD Magazine: Generic Drug Equally Effective in Epilespy

February 22, 2016

Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.